As of 2025-10-31, the Relative Valuation of 9 Meters Biopharma Inc (NMTR) is (39.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 USD, the upside of 9 Meters Biopharma Inc based on Relative Valuation is -54962.4%.
The range of the Relative Valuation is (38.91) - (40.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.3x - 21.8x | 19.8x |
| Forward P/E multiples | 20.8x - 24.4x | 22.6x |
| Fair Price | (38.91) - (40.70) | (39.61) |
| Upside | -53990.8% - -56478.1% | -54962.4% |
| Date | P/E |